Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.460
-0.010 (-0.29%)
At close: Nov 7, 2025, 4:00 PM EST
3.290
-0.170 (-4.91%)
After-hours: Nov 7, 2025, 5:00 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $296.14 million as of November 7, 2025. Its market cap has decreased by -38.37% in one year.
Market Cap
296.14M
Enterprise Value
125.05M
1-Year Change
-38.37%
Ranking
Category
Stock Price
$3.46
Market Cap Chart
Since June 19, 2014, Larimar Therapeutics's market cap has decreased from $410.90M to $296.14M, a decrease of -27.93%. That is a compound annual growth rate of -2.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 297.00M | 20.29% |
| Dec 31, 2024 | 246.90M | 23.57% |
| Dec 29, 2023 | 199.80M | 11.81% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.80M | 692.29% |
| Dec 31, 2019 | 41.50M | -77.26% |
| Dec 31, 2018 | 182.50M | 43.70% |
| Dec 29, 2017 | 127.00M | 46.14% |
| Dec 30, 2016 | 86.90M | -49.27% |
| Dec 31, 2015 | 171.30M | -75.54% |
| Dec 31, 2014 | 700.30M | 70.43% |
| Jun 19, 2014 | 410.90M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |